Telenutrition Center: Examining the Implementation of Behavioral Therapy for Obesity
Telenutrition Center: Examining the Implementation of Behavioral Therapy for Obesity Among Young to Middle Aged African American Adults in Mississippi
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jennifer L Lemacks, PhD
- Phone Number: 601.266.6825
- Email: JENNIFER.LEMACKS@USM.EDU
Study Locations
-
-
Mississippi
-
Hattiesburg, Mississippi, United States, 39406-0001
- The University of Southern Mississippi
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Body mass index >/=28
- 25 to 50 years of age
- history or risk of preventable co-morbidities (ie. diabetes, hypertension, and/or dyslipidemia)
Exclusion Criteria:
- Body mass index <28
- <25 years of age
- >50 years of age
- no history or risk of preventable obesity comorbidities
- Any disease diagnosis (ie. cancer) where weight loss is contraindicated
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Intervention
Enrolled participants will receive the intervention.
|
Approximately 24, 20 minute sessions over 12 months focused on diet and physical activity behavior change goals to promote weight loss.
Framework includes health belief model, transtheoretical model and motivational interviewing.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Changes
Time Frame: 0, 6 and 12 months
|
Weight loss at 0, 6 and 12 months
|
0, 6 and 12 months
|
|
Retention
Time Frame: 12 months
|
Number of enrolled participants who complete the program
|
12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- P20GM103476 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.